| Primary |
| Hypertension |
60.6% |
| Essential Hypertension |
4.7% |
| Diabetes Mellitus |
4.5% |
| Cardiac Failure |
4.1% |
| Blood Pressure |
3.8% |
| Cardiac Failure Congestive |
3.7% |
| Hyperlipidaemia |
1.8% |
| Atrial Fibrillation |
1.7% |
| Prophylaxis |
1.7% |
| Hypercholesterolaemia |
1.6% |
| Type 2 Diabetes Mellitus |
1.4% |
| Blood Pressure Increased |
1.2% |
| Depression |
1.2% |
| Dyslipidaemia |
1.2% |
| Insomnia |
1.2% |
| Osteoporosis |
1.2% |
| Proteinuria |
1.2% |
| Pain |
1.1% |
| Gout |
1.1% |
| Hyperuricaemia |
1.0% |
|
| Drug Ineffective |
11.2% |
| Renal Failure Acute |
10.5% |
| Rhabdomyolysis |
8.6% |
| Hyperkalaemia |
5.4% |
| Renal Failure |
5.4% |
| Wrong Technique In Drug Usage Process |
5.4% |
| Rash |
4.7% |
| Overdose |
4.5% |
| Vomiting |
4.3% |
| Pain In Extremity |
4.1% |
| Pancytopenia |
4.1% |
| Cerebrovascular Accident |
3.9% |
| Malaise |
3.9% |
| Blood Pressure Increased |
3.7% |
| Hypertension |
3.7% |
| Syncope |
3.6% |
| Nausea |
3.4% |
| Palpitations |
3.4% |
| Myocardial Infarction |
3.2% |
| Adverse Event |
3.0% |
|
| Secondary |
| Hypertension |
39.5% |
| Drug Use For Unknown Indication |
19.0% |
| Product Used For Unknown Indication |
11.9% |
| Diabetes Mellitus |
3.5% |
| Acute Myocardial Infarction |
2.4% |
| Osteoporosis |
2.3% |
| Blood Pressure |
2.1% |
| Depression |
2.0% |
| Essential Hypertension |
1.9% |
| Blood Pressure Abnormal |
1.7% |
| Type 2 Diabetes Mellitus |
1.6% |
| Anxiety |
1.6% |
| Atrial Fibrillation |
1.6% |
| Prophylaxis |
1.4% |
| Pain |
1.4% |
| Proteinuria |
1.4% |
| Angina Pectoris |
1.3% |
| Breast Cancer |
1.3% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Hypercholesterolaemia |
1.0% |
|
| Sudden Death |
9.0% |
| Weight Increased |
7.1% |
| Renal Failure Acute |
6.5% |
| Vomiting |
6.3% |
| Wrong Technique In Drug Usage Process |
6.0% |
| Rhabdomyolysis |
5.7% |
| Drug Ineffective |
5.4% |
| Myocardial Infarction |
5.2% |
| Rash |
5.2% |
| Renal Failure |
4.9% |
| Syncope |
4.9% |
| Pain In Extremity |
4.6% |
| Headache |
4.3% |
| Malaise |
3.8% |
| Visual Impairment |
3.8% |
| Hyponatraemia |
3.5% |
| Overdose |
3.5% |
| Palpitations |
3.5% |
| Pruritus |
3.5% |
| Somnolence |
3.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.1% |
| Drug Use For Unknown Indication |
17.8% |
| Hypertension |
16.7% |
| Diabetes Mellitus |
5.4% |
| Blood Cholesterol Increased |
3.4% |
| Pain |
3.0% |
| Rheumatoid Arthritis |
2.9% |
| Type 2 Diabetes Mellitus |
2.9% |
| Blood Pressure |
2.8% |
| Prophylaxis |
2.7% |
| Osteoporosis |
2.7% |
| Depression |
2.6% |
| Atrial Fibrillation |
2.4% |
| Asthma |
2.0% |
| Cardiac Disorder |
2.0% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Multiple Myeloma |
1.6% |
| Anxiety |
1.3% |
| Arthritis |
1.3% |
|
| Weight Decreased |
13.0% |
| Vomiting |
12.2% |
| Weight Increased |
8.2% |
| Myocardial Infarction |
6.3% |
| Nausea |
5.2% |
| Vision Blurred |
4.7% |
| Drug Ineffective |
4.6% |
| Pain |
4.4% |
| Death |
3.9% |
| Urinary Tract Infection |
3.9% |
| Renal Failure |
3.7% |
| Pain In Extremity |
3.6% |
| Pneumonia |
3.5% |
| Dyspnoea |
3.5% |
| Oedema Peripheral |
3.5% |
| Pyrexia |
3.4% |
| Pruritus |
3.2% |
| Somnolence |
3.2% |
| Thrombocytopenia |
3.1% |
| Transient Ischaemic Attack |
2.9% |
|
| Interacting |
| Hypertension |
19.2% |
| Product Used For Unknown Indication |
17.3% |
| Acute Myocardial Infarction |
15.4% |
| Diabetes Mellitus |
8.7% |
| Diabetes Insipidus |
3.8% |
| Type 2 Diabetes Mellitus |
3.8% |
| Blood Cholesterol Increased |
2.9% |
| Cardiac Failure Congestive |
2.9% |
| Neuralgia |
2.9% |
| Podagra |
2.9% |
| Renal Failure |
2.9% |
| Renal Failure Chronic |
2.9% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Glomerulonephritis |
1.9% |
| Hepatic Cirrhosis |
1.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.9% |
| Smoking Cessation Therapy |
1.9% |
| Thrombosis |
1.9% |
| Urticaria |
1.9% |
| Anxiety |
1.0% |
|
| Rash |
25.9% |
| Renal Failure |
11.1% |
| Dizziness Postural |
7.4% |
| Neutropenia |
7.4% |
| Tremor |
7.4% |
| Blood Pressure Decreased |
3.7% |
| Drug Interaction |
3.7% |
| Hypertension |
3.7% |
| Hypotension |
3.7% |
| International Normalised Ratio Increased |
3.7% |
| Nausea |
3.7% |
| Orthostatic Hypotension |
3.7% |
| Renal Failure Acute |
3.7% |
| Sluggishness |
3.7% |
| Urticaria |
3.7% |
| Vertigo |
3.7% |
|
